Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 10/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | GPR183 | P32249 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.37 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19667656 | 0.88 | ESR2 (0.42) | PTGDR2TMEM97SIGMAR1 | |
| SCHEMBL30207824 | 0.88 | ESR2 (0.42) | PTGDR2TMEM97SIGMAR1 | |
| SCHEMBL29118122 | 0.80 | MEN1 (0.34) | KMT2ANPC1MEN1SMN1; SMN2 | |
| SCHEMBL29118109 | 0.80 | L3MBTL1 (0.38) | PTGDR2L3MBTL1GPR183CHRNA7TMEM97 | |
| SCHEMBL29118088 | 0.79 | L3MBTL1 (0.43) | PTGDR2L3MBTL1GPR183CHRNA7TMEM97 | |
| SCHEMBL29118114 | 0.79 | GPR119 (0.43) | PTGDR2L3MBTL1GPR183CHRNA7 | |
| SCHEMBL29118124 | 0.77 | PTGDR2 (0.42) | PTGDR2L3MBTL1GPR183CHRNA7TMEM97 | |
| SCHEMBL29118086 | 0.77 | MAOA (0.42) | PTGDR2L3MBTL1GPR183CHRNA7TMEM97 | |
| SCHEMBL29118090 | 0.77 | MAOB (0.46) | PTGDR2L3MBTL1GPR183CHRNA7TMEM97 | |
| SCHEMBL29118130 | 0.76 | TMEM97 (0.42) | PTGDR2L3MBTL1GPR183CHRNA7TMEM97 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109890797-B | Substituted carbon nucleoside derivatives useful as anticancer agents | 辉瑞公司 | 2023-02-28 | — | — | CN | disclosed |